Humana Reports 20% Enrollment in High-Rated Medicare Advantage Plans for 2026

What's Happening?

Humana has announced that approximately 20% of its members are enrolled in Medicare Advantage (MA) plans that are projected to receive at least four stars in the 2026 ratings. This information was disclosed in a filing with the Securities and Exchange Commission, following an inadvertent early release of the data on the CMS Plan Finder. The preliminary data indicates that 1.2 million individuals are enrolled in plans with at least four stars, with 14% in plans rated at 4.5 stars. The average star rating for Humana's plans is 3.61. Despite these figures, Humana expressed dissatisfaction with the 2026 results, attributing the performance to limited time for improvement following a downturn in 2025. The company is focusing on diversifying its MA contracts to enhance future performance, expecting significant improvements in the 2027 star ratings.

Why It's Important?

The star ratings for Medicare Advantage plans are crucial as they influence consumer choice and can impact the financial performance of insurers. High ratings can attract more enrollees, leading to increased revenue and market share. For Humana, achieving higher ratings is essential to maintaining competitiveness in the Medicare Advantage market. The company's efforts to diversify its contracts and improve plan design are strategic moves to enhance its offerings and regain membership growth. This development is significant for stakeholders, including investors and policyholders, as it reflects Humana's commitment to improving service quality and financial stability.

What's Next?

Humana plans to continue its efforts to diversify its Medicare Advantage contracts and improve plan design, aiming for better performance in future star ratings. The company anticipates that these efforts will lead to a return to membership growth in 2026. Stakeholders will be watching closely to see if Humana's strategies result in the expected improvements in the 2027 star ratings. The company's reaffirmation of its 2025 financial guidance suggests confidence in its strategic direction, but the actual impact will depend on the successful implementation of its plans.